Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
GRI Bio, Inc. (GRI) had Income from Continuous Operations of $-11.96M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-11.96M |
|
-- |
|
-- |
|
$11.98M |
|
$-11.98M |
|
$0.02M |
|
$-11.96M |
|
$-11.96M |
|
$-11.96M |
|
|
Income from Continuous Operations |
$-11.96M |
$-11.96M |
|
$-11.96M |
|
$-11.98M |
|
$-11.97M |
|
0.10M |
|
0.10M |
|
$-121.80 |
|
$-121.80 |
|
| Balance Sheet Financials | |
$8.59M |
|
$0.00M |
|
$0.07M |
|
$8.67M |
|
$2.64M |
|
-- |
|
$0.01M |
|
$2.66M |
|
$6.01M |
|
$6.01M |
|
$6.01M |
|
0.50M |
|
| Cash Flow Statement Financials | |
$-10.19M |
|
$-0.00M |
|
$13.39M |
|
$5.03M |
|
$8.23M |
|
$3.20M |
|
$0.79M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.25 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-10.19M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-199.00% |
|
-199.00% |
|
-137.96% |
|
-199.00% |
|
$12.06 |
|
$-103.80 |
|
$-103.77 |
|